• PCAM rendering

Scholarship

with Impact.

Dominic Sisti, PhD, Andrea Segal, MS, and Michael Thase, MD

Proceed With Caution: Off-Label Ketamine Treatment for Major Depressive Disorder

Current Psychiatry Reports, October 2014
Article
  • 20121230 095126

Ketamine offers a promising new option for the treatment of depression, but its increasing off-label use is ethically and clinically inappropriate at the moment.

ABSTRACT

General

Title

More Info